Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Xeris Biopharma reported a quarterly loss of $0.14 per share, missing estimates. - Xeris Biopharma posted revenues of $40.64 million, missing estimates by 2.21%. - Xeris Biopharma shares have lost 21.3% this year, underperforming the S&P 500. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- Xeris Biopharma reported a quarterly loss of $0.14 per share, missing estimates.
- Xeris Biopharma posted revenues of $40.64 million, missing estimates by 2.21%.
- Xeris Biopharma shares have lost 21.3% this year, underperforming the S&P 500.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.